As science continues to unravel the benefits of hemp and cannabinoids, each day is delivering exciting new potential. One such study is offering enormously fascinating information on the possibility for hemp compounds to aid in the prevention of coronavirus.
A recent study by Richard van Breemen, a researcher with Oregon State’s Global Hemp Innovation Center, College of Pharmacy and Linus Pauling Institute, has shined a possible light on Cannabis sativa potentially stopping coronavirus from entering human cells. The key here is in cannabinoid acids binding to SARS-CoV-2 spike proteins, blocking a vital process in the human infection stage.
These acids, known as cannabigerolic acid (CBGA) and cannabidiolic acid (CBDA), are abundant in hemp and hemp extracts, and are considered very safe in humans. Early findings are revealing the potential for these acids to bind with the RNA proteins that make up the SARS-CoV-2 virus, including the very important spike protein which is essential in the replication and growth of the virus in the human body.
“The compounds can be taken orally and have a long history of safe use in humans,” said van Breemen. “They have potential to prevent as well as treat infection by SARS-CoV-2.”
If these findings hold up, this would represent not only an important tool in the fight against coronavirus, but further vindication and revelations into the ongoing research of hemp and the benefits of cannabinoids. Already, many studies are showing promise in the benefits of cannabinoids in pain treatment, fighting depression, sleep management, and aiding in focus and overall mental health to name a few.